- Home
- BAOS vs KZIA Comparison
BAOS vs KZIA Comparison
Compare BAOS & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BAOS
- KZIA
- Stock Information
- Founded
- BAOS 2018
- KZIA 1994
- Country
- BAOS China
- KZIA Australia
- Employees
- BAOS N/A
- KZIA N/A
- Industry
- BAOS Business Services
- KZIA Biotechnology: Pharmaceutical Preparations
- Sector
- BAOS Consumer Discretionary
- KZIA Health Care
- Exchange
- BAOS Nasdaq
- KZIA Nasdaq
- Market Cap
- BAOS 6.5M
- KZIA 6.0M
- IPO Year
- BAOS 2021
- KZIA 1999
- Fundamental
- Price
- BAOS $3.21
- KZIA $0.88
- Analyst Decision
- BAOS
- KZIA Strong Buy
- Analyst Count
- BAOS 0
- KZIA 2
- Target Price
- BAOS N/A
- KZIA $11.50
- AVG Volume (30 Days)
- BAOS 380.1K
- KZIA 5.5M
- Earning Date
- BAOS 01-01-0001
- KZIA 03-26-2025
- Dividend Yield
- BAOS N/A
- KZIA N/A
- EPS Growth
- BAOS N/A
- KZIA N/A
- EPS
- BAOS N/A
- KZIA N/A
- Revenue
- BAOS $859,226.00
- KZIA $1,655,324.00
- Revenue This Year
- BAOS N/A
- KZIA N/A
- Revenue Next Year
- BAOS N/A
- KZIA N/A
- P/E Ratio
- BAOS N/A
- KZIA N/A
- Revenue Growth
- BAOS N/A
- KZIA 248000.00
- 52 Week Low
- BAOS $1.44
- KZIA $0.85
- 52 Week High
- BAOS $13.66
- KZIA $15.80
- Technical
- Relative Strength Index (RSI)
- BAOS 49.19
- KZIA 29.00
- Support Level
- BAOS $3.02
- KZIA $0.90
- Resistance Level
- BAOS $3.42
- KZIA $1.60
- Average True Range (ATR)
- BAOS 0.36
- KZIA 0.14
- MACD
- BAOS -0.05
- KZIA 0.02
- Stochastic Oscillator
- BAOS 19.00
- KZIA 4.00
About BAOS Baosheng Media Group Holdings
Baosheng Media Group Holdings Ltd operates as a V-log streaming marketing service provider. The firm offers comprehensive marketing solutions. Its services are Internet effect marketing, V-log or short video streaming marketing including content production and operation, e-commerce marketing, original big data platform system service, and AI technology. It provides one-stop and full-link deep customized marketing solutions for partners. Baosheng Group is also a core agency of domestic Internet companies such as Tencent, Alibaba, Bytedance, and Kuaishou, with performing channel marketing services, technologies, and applications.
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.